U.S. flag

An official website of the United States government

NM_000135.4(FANCA):c.2602-13CT[2] AND Fanconi anemia complementation group A

Clinical significance:Likely pathogenic (Last evaluated: Dec 15, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV001523811.2

Allele description [Variation Report for NM_000135.4(FANCA):c.2602-13CT[2]]

NM_000135.4(FANCA):c.2602-13CT[2]

Gene:
FANCA:FA complementation group A [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_000135.4(FANCA):c.2602-13CT[2]
HGVS:
  • NC_000016.10:g.89765074AG[2]
  • NG_011706.1:g.56579CT[2]
  • NM_000135.4:c.2602-13CT[2]MANE SELECT
  • NM_001286167.3:c.2602-13CT[2]
  • LRG_495t1:c.2602-9_2602-8del
  • LRG_495:g.56579CT[2]
  • NC_000016.9:g.89831482AG[2]
  • NC_000016.9:g.89831482_89831483del
  • NM_000135.2:c.2602-9_2602-8del
  • NM_000135.2:c.2602-9_2602-8delCT
  • NM_000135.3:c.2602-9_2602-8del
  • NM_000135.4:c.2602-9_2602-8delCTMANE SELECT
Links:
dbSNP: rs577636020
NCBI 1000 Genomes Browser:
rs577636020
Molecular consequence:
  • NM_000135.4:c.2602-13CT[2] - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001286167.3:c.2602-13CT[2] - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Fanconi anemia complementation group A
Synonyms:
Fanconi anemia, group A
Identifiers:
MONDO: MONDO:0009215; MedGen: C3469521; Orphanet: 84; OMIM: 227650

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001478120Department of Pediatrics,Memorial Sloan Kettering Cancer Centercriteria provided, single submitter
Likely pathogenic
(Dec 15, 2020)
germlineresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedresearch

Citations

PubMed

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, Pradhan N, Arnold A, Walsh MF, Li Y, Balakrishnan AR, Syed A, Prasad M, Nafa K, Carlo MI, Cadoo KA, Sheehan M, Fleischut MH, Salo-Mullen E, Trottier M, Lipkin SM, Lincoln A, et al.

JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137. Erratum in: JAMA. 2018 Dec 11;320(22):2381.

PubMed [citation]
PMID:
28873162
PMCID:
PMC5611881

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Department of Pediatrics,Memorial Sloan Kettering Cancer Center, SCV001478120.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 21, 2023